Neonatal respiratory care
Research activity includes less invasive surfactant administration and premedication strategies for newborns with respiratory distress syndrome, with attention to safety and tolerance of procedural care.
- Surfactant treatment
- Ketamine and fentanyl premedication
- Adverse event reduction
The clinical focus is on neonatal support in intensive care settings and the optimisation of respiratory interventions.
Cardiometabolic health
Trials examine the relationship between glucose metabolism, lipid metabolism, and cardiovascular function, with interest in metabolic and vascular risk profiles.
- Metabolic syndrome
- Cardiovascular disease risk factors
- Cardiovascular function
Research in this area addresses interconnected metabolic and cardiovascular pathways relevant to chronic disease prevention.
Endocrine and metabolic pharmacology
Investigation extends to roxadustat and its effects on cardiometabolism, reflecting interest in treatments that may influence systemic metabolic regulation.
- Glucose regulation
- Lipid regulation
- Cardiovascular effects
The therapeutic scope includes metabolic responses and cardiovascular outcomes linked to pharmacological intervention.
Women’s health and contraception
Clinical research covers combined contraceptives and progestin-only approaches, including evaluation in women with polycystic ovary syndrome and assessment of coagulation-related effects.
- Contraception
- Coagulation
- Polycystic ovary syndrome
Interest is centred on hormonal therapies, thrombotic risk markers, and reproductive endocrinology.
